Market Tracker

07/21 5:16pm ET

Mesoblast Ltd (NASDAQ:MESO)

7.71
Delayed Data
As of Jul 21
 -0.04 / -0.52%
Today’s Change
4.01
Today|||52-Week Range
12.50
+44.11%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close7.75
Today’s open7.68
Day’s range7.67 - 7.73
Volume6,012
Average volume (3 months)33,681
Market cap$654.5M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-212.26%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
OFIXOrthofix Internation...-0.35-0.76%
IVCInvacare Corp-0.35-2.66%
RTIXRTI Surgical Inc-0.05-0.88%
SIENSientra Inc+0.01+0.09%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 23, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts